Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eton Pharmaceuticals (ETON) Enterprise Value (2019 - 2025)

Eton Pharmaceuticals' Enterprise Value history spans 7 years, with the latest figure at -$37.1 million for Q3 2025.

  • For Q3 2025, Enterprise Value fell 83.21% year-over-year to -$37.1 million; the TTM value through Sep 2025 reached -$37.1 million, down 83.21%, while the annual FY2024 figure was -$14.9 million, 30.17% up from the prior year.
  • Enterprise Value for Q3 2025 was -$37.1 million at Eton Pharmaceuticals, down from -$25.4 million in the prior quarter.
  • Across five years, Enterprise Value topped out at -$13.4 million in Q3 2022 and bottomed at -$37.1 million in Q3 2025.
  • The 5-year median for Enterprise Value is -$17.7 million (2024), against an average of -$20.0 million.
  • The largest annual shift saw Enterprise Value plummeted 209.72% in 2021 before it soared 41.09% in 2022.
  • A 5-year view of Enterprise Value shows it stood at -$14.4 million in 2021, then decreased by 13.18% to -$16.3 million in 2022, then crashed by 31.17% to -$21.4 million in 2023, then surged by 30.17% to -$14.9 million in 2024, then crashed by 148.53% to -$37.1 million in 2025.
  • Per Business Quant, the three most recent readings for ETON's Enterprise Value are -$37.1 million (Q3 2025), -$25.4 million (Q2 2025), and -$17.4 million (Q1 2025).